News

11:15 AMYahoo Finance

Eli Lilly secures first approval for weight-loss pill in China

LLY−0.5%NVO−1.1%

10:35 AMYahoo Finance

Novo and DJ khaled team up to take fans behind the scenes of the iconic musician's real-life "Walk, Golf, and Wegovy®" diet and weight-loss routine

NVO−1.1%

9:35 PMYahoo Finance

JPMorgan predicted strong Wegovy pill sales (and was right). Is Novo Nordisk stock a buy now?

JPM−0.2%NVO−1.1%

7:24 PMYahoo Finance

Novo Nordisk (CPSE:NOVO B) stock still looks undervalued as shares fell 56%

NVO−1.1%

12:55 PMYahoo Finance

Hims & Hers climbs 6% despite Five States Joining FTC Suit; Eli Lilly dips, Novo Nordisk holds Steady

NVO−1.1%

1:52 PMYahoo Finance

Hims & Hers drops 18% as Q3 loss and profit outlook cut Disappoint; Novo Nordisk slides 2%, Eli Lilly holds Steady

NVO−1.1%

11:04 AMYahoo Finance

Eli Lilly vs Novo Nordisk: What's the better GLP-1 stock to buy?

NVO−1.1%

8:00 AMYahoo Finance

Investors Heavily Search Novo Nordisk A/S (NVO): Here is what you need to know

NVO−1.1%

7:41 AMYahoo Finance

The FDA ordered GLP-1 vision-loss warnings for Some Products. Shares of Eli Lilly and Novo Nordisk were unfazed.

LLY−0.5%NVO−1.1%

6:13 AMYahoo Finance

What does Novo Nordisk (CPSE:NOVO B) FDA vision warning mean for investors?

NVO−1.1%

12:06 PMYahoo Finance

FDA requires vision-loss warning on Novo Nordisk and Eli Lilly GLP-1 drugs

NVO−1.1%LLY−0.5%

8:41 AMYahoo Finance

Novo Nordisk reveals surprising new Benefit for Wegovy

NVO−1.1%

7:29 AMYahoo Finance

Novo Nordisk A/S - share repurchase programme

NVO−1.1%

3:35 PMYahoo Finance

Novo Nordisk's Wegovy pill has topped 5 million prescriptions. Is the stock a buy now?

NVO−1.1%

3:14 PMYahoo Finance

What Novo Nordisk A/S (NVO) said on its Q3 earnings call

NVO−1.1%

2:11 PMYahoo Finance

Novo post hoc analysis finds Wegovy® 2.4 mg was associated with improvements in liver markers in adults with MASH with liver scarring and a BMI less than 27 kg/m2, presented at the Liver Meeting® (AASLD) 2026

NVO−1.1%

6:40 PMYahoo Finance

Novo Nordisk just delivered great news for investors. Is a Comeback Finally Underway?

NVO−1.1%

4:17 AMYahoo Finance

Novo Nordisk (CPSE:NOVO B) shares in focus after Fresh Wegovy MASH data

NVO−1.1%

3:07 PMYahoo Finance

Novo real-world studies link Wegovy® 2.4 mg to reductions in liver enzymes, weight, and blood sugar in adults with MASH at the Liver Meeting® (AASLD) 2026

NVO−1.1%

8:32 AMCNBC

Stocks making the biggest moves premarket: Trump Media, Tesla, CoreWeave, Novo Nordisk and more

TSLA+1.7%NVO−1.1%

10:03 AMYahoo Finance

Eli Lilly jumps 8% as strong quarter lifts revenue outlook; Novo Nordisk Ticks up, Viking Therapeutics eases

NVO−1.1%VKTX−3.0%